Lilly Bamlanivimab Antibody Playbook

Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Related Content

Flipping the Script on Medication Errors

Pharmacy teams are utilizing innovative approaches to prevent adverse drug effects.

Nov. 10, 2023

CHA Submits Statement for the Record for Drug Shortages Hearing

Children's Hospital Association submitted a statement for a legislative hearing to highlight children’s needs when strengthening the pediatric drug supply chain.

Sep. 14, 2023

CHA Letter to Senate HELP Committee on Markup of PAHPA Reauthorization Legislation

The letter urges lawmakers to prioritize children’s physical and mental health needs in its markup of the Pandemic and All-Hazards Preparedness and Response Act (PAHPA).

July 27, 2023